Work

Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study

Year: 2020

Type: article

Study design: Observational Study

Source: Clinical Infectious Diseases

DOI: 10.1093/cid/ciaa802

Authors: Alexandre E Malek, Melissa Khalil, Ray Hachem, Anne Marie Chaftari, Johny Fares, Ying Jiang, Dimitrios P Kontoyiannis, Frank Fossella, Patrick Chaftari, Victor E Mulanovich, George M Viola, Issam I Raad

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3036517838

FWCI: 0.809

Cites: 20

Cited by: 16

Related to: 10